A recent rodent study [143] showed that similarly to Treg cells, B cells can produce CD19+ EVs carrying CD39 and CD73, which hydrolyse extracellular ATP released from chemotherapy-treated cancer cells to suppress cytotoxic Teff cell function [144]. The gene discussed is ENTPD1; the disease is cancer.